SRI Awarded National Institute on Drug Abuse Contract for Chemical ... MarketWatch - ... applications to start human clinical trials -- and specializes in cancer, immunology and inflammation, infectious disease, and neuroscience research. ... |
« Thallion Initiates Enrollment in Phase II Metastatic Melanoma Trial - MarketWatch | Main | Philips Unveils Intelligent Pill for Digestive Tract Diseases - DOTmed.com (press release) »
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e54ed2f120883301053625d742970b
Listed below are links to weblogs that reference SRI Awarded National Institute on Drug Abuse Contract for Chemical ... - MarketWatch:
This is only a preview. Your comment has not yet been posted.
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
Comments